Pharmadrug Inc. (CSE: PHRX)

Market Cap	2.15M
Revenue (ttm)	n/a
Net Income (ttm)	-13.29M
Shares Out	107.70M
EPS (ttm)	-0.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.0200
Previous Close	0.0200
Day's Range	0.0200 - 0.0200
52-Week Range	0.0050 - 0.0750
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2024

About Pharmadrug

Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally derived approved drugs. The company also engages in the researching and reformulating of established natural medicines; development of synthetic formulations of existing drugs for potential commercialization and distribution; development of cepharanthine, a drug for the treatment of infectious disease and rare cancers; and rese...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Robert Steen
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PHRX